HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
R Bolli Selected Research
R Bolli Research Topics
Disease
7
Infarction (Infarctions)
12/2005 - 11/2000
6
Myocardial Infarction
04/2014 - 08/2000
6
Ischemia
11/2001 - 11/2000
5
Coronary Occlusion
07/2001 - 08/2000
3
Myocardial Ischemia (Ischemic Heart Diseases)
07/2014 - 04/2001
3
Cardiomegaly (Heart Hypertrophy)
12/2001 - 06/2000
3
Myocardial Stunning (Stunned Myocardium)
09/2001 - 08/2000
2
Heart Diseases (Heart Disease)
05/2009 - 09/2001
2
Hypertrophy
12/2001 - 09/2001
2
Heart Failure
12/2001 - 01/2001
2
Reperfusion Injury
09/2001 - 04/2001
1
Cicatrix (Scar)
12/2013
1
Cardiomyopathies (Cardiomyopathy)
12/2005
1
Acute Coronary Syndrome
01/2001
1
Hypoxia (Hypoxemia)
01/2001
1
Septic Shock (Toxic Shock Syndrome)
01/2001
1
Headache (Headaches)
07/2000
Drug/Important Bio-Agent (IBA)
4
Protein Kinase C
IBA
12/2001 - 06/2000
3
Purinergic P1 Receptors (Adenosine Receptor)
IBA
09/2001 - 03/2001
3
N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosine
IBA
09/2001 - 03/2001
3
N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamide
IBA
08/2001 - 08/2000
3
Nitric Oxide Synthase (NO Synthase)
IBA
07/2001 - 11/2000
2
Protein Isoforms (Isoforms)
IBA
12/2001 - 06/2000
2
Protein Kinase C-epsilon
IBA
12/2001 - 06/2000
2
Enzymes
IBA
11/2001 - 08/2000
2
Nitric Oxide (Nitrogen Monoxide)
FDA Link
11/2001 - 11/2000
2
Adenosine (Adenocard)
FDA Link
Generic
11/2001 - 08/2001
2
N 0861
IBA
09/2001 - 03/2001
2
Proteins (Proteins, Gene)
FDA Link
07/2001 - 08/2000
2
Tyrosine (L-Tyrosine)
FDA Link
07/2001 - 11/2000
2
Phosphotransferases (Kinase)
IBA
07/2001 - 11/2000
2
5-hydroxydecanoic acid
IBA
03/2001 - 11/2000
2
Adenosine Triphosphate (ATP)
IBA
03/2001 - 11/2000
2
Nitroarginine (NG Nitro L Arginine)
IBA
03/2001 - 11/2000
1
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
04/2014
1
Receptors for Activated C Kinase
IBA
12/2001
1
Nexus
IBA
12/2001
1
Protein Kinase C beta
IBA
12/2001
1
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
11/2001
1
Endotoxins
IBA
11/2001
1
Opioid Analgesics (Opioids)
IBA
11/2001
1
Peptides (Polypeptides)
IBA
09/2001
1
Isoenzymes
IBA
09/2001
1
Nitrates
IBA
08/2001
1
Nitroglycerin (Dynamite)
FDA Link
Generic
08/2001
1
Adenosine A1 Receptor
IBA
08/2001
1
Adenosine A3 Receptor
IBA
08/2001
1
alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamide
IBA
07/2001
1
Antibodies
IBA
07/2001
1
Phosphotyrosine
IBA
07/2001
1
Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)
IBA
04/2001
1
Superoxide Dismutase
IBA
04/2001
1
2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosine
IBA
03/2001
1
Potassium
IBA
03/2001
1
I-kappa B Proteins (I kappa B)
IBA
01/2001
1
Free Radicals
IBA
01/2001
1
Cytokines
IBA
01/2001
1
NF-kappa B (NF-kB)
IBA
01/2001
1
Lipopolysaccharides
IBA
01/2001
1
chelerythrine
IBA
11/2000
1
triphenyltetrazolium
IBA
11/2000
1
Glycine (Aminoacetic Acid)
FDA Link
Generic
11/2000
1
Oxidants (Oxidizing Agents)
IBA
11/2000
1
Diazoxide (Hyperstat)
FDA Link
11/2000
1
Calcium
IBA
11/2000
1
Antioxidants
IBA
11/2000
1
Nitric Oxide Donors
IBA
11/2000
1
Tyrosine Kinase Inhibitors
IBA
11/2000
1
S-Nitroso-N-Acetylpenicillamine
IBA
11/2000
1
lavendustin A
IBA
11/2000
1
Messenger RNA (mRNA)
IBA
08/2000
1
Celecoxib (Celebrex)
FDA Link
08/2000
1
Prostaglandins
IBA
08/2000
1
Ribonucleases (Ribonuclease)
IBA
08/2000
1
Intravenous Immunoglobulins (IVIG)
FDA Link
07/2000
1
Ventricular Myosins
IBA
06/2000
Therapy/Procedure
3
Therapeutics
07/2014 - 12/2013
2
Cell- and Tissue-Based Therapy (Cell Therapy)
05/2009 - 12/2005